
Sensei Biotherapeutics Surges on Faeth Acquisition and $200M Investment
Sensei Biotherapeutics stock surged 230% after acquiring Faeth Therapeutics and securing $200M investment, expanding its oncology pipeline with PIKTOR therapy.
SNSEacquisitionbiotech